HPV vaccine ‘could substantially reduce’ cervical cancer incidence

Date of publication: November 2011

Publication type: News item

In a nutshell: Research published in the Lancet Oncology says the human papillomavirus (HPV) vaccine Cervarix “offers excellent protection” against serious cell changes that lead to cervical cancer, particularly when given to young adolescent girls before they become sexually active.

Length of publication: Webpage

This entry was posted on Friday, November 25th, 2011 at 4:01 pm and is filed under Gynaecologic cancer, National policy, News item, Preventive measures, Volume 3 Issue 9, Young people. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

Cancer Horizon Scanning